PuSH - Publication Server of Helmholtz Zentrum München

Shortening the paths to type 1 diabetes mellitus prevention.

Nat. Rev. Endocrinol. 17, 73–74 (2021)
Publ. Version/Full Text DOI PMC
Closed
Open Access Green as soon as Postprint is submitted to ZB.
The development and application of effective immunotherapies for type 1 diabetes mellitus has lagged behind our ability to identify and stage individuals in pre-clinical stages of disease. This Year in Review addresses advances in immunotherapy aimed towards prevention and our readiness to roll out screening in the broader population.
Scopus
Cited By
Altmetric
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Editorial
Language
Publication Year 2021
Prepublished in Year 2020
HGF-reported in Year 2020
ISSN (print) / ISBN 1759-5029
e-ISSN 1759-5037
Quellenangaben Volume: 17, Issue: , Pages: 73–74 Article Number: , Supplement: ,
Publisher Nature Publishing Group
Publishing Place New York, NY
Reviewing status Peer reviewed
Institute(s) Institute of Pancreatic Islet Research (IPI)
Institute of Diabetes and Obesity (IDO)
Institute of Diabetes Research (IDF)
POF-Topic(s) 90000 - German Center for Diabetes Research
30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-502600-006
G-501900-229
G-502100-001
Scopus ID 85096943106
PubMed ID 33257822
Erfassungsdatum 2020-12-15